Definitive Contract HHSN268201400011C
Award Date 11/14/13
Potential Completion Date 11/14/16
Potential Value $1.6M
Federal Agency
Awardee
Ultimate Awardee
Not listed NAICS Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Cost No Fee
Place of Performance
Morrisville, NC, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
31
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- <p>The Department of the Army Medical Command awarded a Definitive, Firm Fixed Price contract to Humacyte Global Inc. (doing business as Humacyte) for a Phase 2 Clinical Trial. The contract has a potential value of $4,025,472.00 and a completion date of March 29, 2020. The contract was awarded on September 30, 2017 and does not have a set-aside designation. Humacyte is a for-profit manufacturer of goods.</p>
- This is a federal contract awarded by the National Heart Lung and Blood Institute (NHLBI), a civilian agency, to the Allegheny Singer Research Institute (AHN Research Institute) to conduct a study exploring the feasibility of using combined modalities to test the safety of the CardioMEMS device in patients with pulmonary arterial hypertension (PAH). The contract, valued at $778,004.14, is for the VASCULAR INTERVENTIONS/INNOVATIONS AND THERAPEUTIC ADVANCES (VITA) program and has a definitive...
- This is a $1,809,248.54 cost-type definitive contract awarded by the National Heart Lung and Blood Institute (NHLBI), a component of the National Institutes of Health (NIH), to The Regents of the University of California, San Francisco (UCSF) for the "Prevention of Anastomotic Intimal Hyperplasia by a Pro-Resolving Perivascular Device" research project. The contract supports the development and testing of a medical device designed to prevent a cardiovascular condition called...
- This federal contract award, with an ID of HHSN268201400005C, was issued by the National Heart Lung and Blood Institute (NHLBI), a civilian agency, to the Regents of the University of California, San Francisco (UCSF). The contract is for the "VASCULAR INTERVENTIONS/INNOVATIONS AND THERAPEUTIC ADVANCES (VITA): PRO-RESOLVING VASCULAR DEVICES" program, with a base period from November 15, 2013 to November 14, 2014 and a total completion date of November 14, 2016. The contract, which is...
- This is a $97,680 firm fixed price contract awarded by the National Heart Lung and Blood Institute, a civilian agency within the U.S. Department of Health and Human Services. The contract was set aside for small businesses and awarded to Mediomics LLC, a woman-owned small business. The contract is for the development of APTAMER-BASED PINCERS FOR CARDIOVASCULAR BIOMARKERS, which aligns with the National Heart Lung and Blood Institute's mission to support research on heart, lung, and blood...
- <p>This is a $99,963.00 firm-fixed-price definitive contract awarded by the National Heart Lung and Blood Institute, a civilian agency under the U.S. Department of Health and Human Services, to Heartflow, Inc., a for-profit Subchapter S corporation. The contract is for biomedical (applied/exploratory) research and development, with a period of performance from August 1, 2008 to April 1, 2009. The contract has a total small business set-aside designation.</p>
- This is a $99,911 Small Business Innovation Research (SBIR) Phase I contract awarded by the National Heart, Lung, and Blood Institute (NHLBI), a civilian agency under the Department of Health and Human Services (HHS). The contract was awarded to Luna Innovations Incorporated, a small business manufacturer specializing in advanced fiber optic sensing and measurement systems. The contract supports the development of "Critical Technologies for Ventricular Assist Devices," a research...
- The Department of Health and Human Services National Institutes of Health National Heart Lung and Blood Institute awarded a $1,100,000.00 firm-fixed-price purchase order contract to Transmural Systems LLC, a woman-owned small business, for the manufacture of 200 Active Guidewires for MRI-guided cardiovascular catheterization. This contract is part of the National Heart, Lung, and Blood Institute's Division of Intramural Research's efforts to develop radiation-free heart catheterization...
- This federal contract award with ID HHSN268200700021C was made by the National Heart Lung and Blood Institute, a civilian agency within the Department of Health and Human Services, to Biosurfaces Inc., a for-profit small business. The $100,000 firm fixed-price contract is for the development of critical technologies for ventricular assist devices under the SBIR Phase I program. The contract has a period of performance from September 30, 2007 to June 17, 2009. Biosurfaces Inc. specializes in...
- This is a $171,943.73 firm fixed-price purchase order awarded by the Department of Health and Human Services (HHS) National Institutes of Health (NIH) National Heart Lung and Blood Institute to National Collegiate Inventors & Innovators Alliance, Inc. (doing business as Venturewell), a non-profit organization. The contract, which does not have a set-aside designation, is for a DEBUT CHALLENGE with a completion date of August 31, 2024. Venturewell has previously served as both a prime...